LMT
45
-5
AAPL
36
-6
EA
30
-6
VZ
40
-2
GLW
53
-3
BRK.B
45
-2
STX
52
-4
MAT
43
-4
L
59
-4
FLR
38
-4
SPG
53
-2
CSX
37
-6
KEY
46
-7
XOM
42
-3
SLG
53
-13
LEG
11
-3
CSCO
37
-4
K
60
9
LRCX
42
-4
KMX
48
-2
LMT
45
-5
AAPL
36
-6
EA
30
-6
VZ
40
-2
GLW
53
-3
BRK.B
45
-2
STX
52
-4
MAT
43
-4
L
59
-4
FLR
38
-4
SPG
53
-2
CSX
37
-6
KEY
46
-7
XOM
42
-3
SLG
53
-13
LEG
11
-3
CSCO
37
-4
K
60
9
LRCX
42
-4
KMX
48
-2
Financhill
Back

ACADIA Pharmaceuticals Quote, Financials, Valuation and Earnings

Wall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%

Click here to see his new prediction.
Sell
46

ACAD
ACADIA Pharmaceuticals

Last Price:
16.07
Seasonality Move:
8.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Potential crash warning signs flashing again on my charts

Here's my #1 indicator to try out now.

ACADIA Pharmaceuticals Price Quote

$16.07

ACADIA Pharmaceuticals Key Stats

Sell
46
ACADIA Pharmaceuticals (ACAD) is a Sell
Day range:
$15.76 - $16.46
52-week range:
$14.55 - $32.59
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.99
P/B ratio:
5.16%
Volume:
856K
Avg. volume:
1.8M
1-year change:
-40.72%
Market cap:
$2.7B
Revenue:
$726.4M
EPS:
$0.18

How Much Does ACADIA Pharmaceuticals Make?

Is ACADIA Pharmaceuticals Growing As A Company?

ACADIA Pharmaceuticals Stock Price Performance

What Is ACADIA Pharmaceuticals 52-Week High & Low?

ACADIA Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy ACADIA Pharmaceuticals?

Is ACADIA Pharmaceuticals Cash Flow Positive?

  • What Is ACAD Cash Flow From Operations?
    Cash flow from operations (TTM) is $80.5M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $22.8M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$36.5M

ACADIA Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ACAD return on invested capital is 7.04%
  • What Is ACADIA Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 4.03%
  • What Is ACAD Return On Equity?
    ROE is a measure of profitability and is 7.04%

ACADIA Pharmaceuticals Earnings Date & Stock Price

ACADIA Pharmaceuticals Competitors

ACADIA Pharmaceuticals Dividend Yield

ACADIA Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 1900% 13.9%
Revenue: 46.44% 2.67%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 25.11
Upside from Last Price: 56.22%

Major Shareholders

  • How many ACAD shares are owned by institutional investors?
    226.6M ACAD shares are owned by institutional investors
  • How many ACAD shares are owned by insiders?
    1.1M ACAD shares are owned by insiders